ArticleJournal of Zhejiang University. Science. B2022
Romidepsin (FK228) improves the survival of allogeneic skin grafts through downregulating the production of donor-specific antibody via suppressing the IRE1α-XBP1 pathway.
Yuliang Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.